{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T04:32:47Z","timestamp":1793248367793,"version":"4.5.0"},"reference-count":37,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"7","license":[{"start":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T00:00:00Z","timestamp":1780963200000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2026,7]]},"abstract":"<jats:sec>\n                    <jats:title>Background and objectives:<\/jats:title>\n                    <jats:p>Food allergy, particularly peanut allergy, is a significant and growing health concern, especially in high-income countries. Affecting 2% of children and 1% of adults, peanut allergy is a chronic condition that severely impacts quality of life. The standard treatment remains allergen avoidance, though oral immunotherapy (OIT) has emerged as a potential strategy for desensitization. This systematic review and meta-analysis aims to evaluate the efficacy and safety of peanut oral immunotherapy (POIT) based on randomized controlled trials (RCTs).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods:<\/jats:title>\n                    <jats:p>A systematic review and meta-analyses were conducted following PRISMA guidelines. Eligible studies included double-blind RCTs evaluating POIT versus placebo or avoidance. Databases such as PubMed, Google Scholar, Cochrane-Controlled Register of Trials, and ClinicalTrials.gov were searched. Risk of bias was assessed using the Cochrane Risk of Bias tool (ROB2), and statistical analysis was performed using the RevMan software.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results:<\/jats:title>\n                    <jats:p>\n                      A total of 20 studies with 2161 participants (median age: 8.6\u00a0years) were included. POIT demonstrated a significant increase in desensitization rates (RR\u00a0=\u00a07.25, 95% CI: 2.66\u201319.79,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =\u00a00.0001). However, POIT was also associated with increased risks of anaphylaxis (RR\u00a0=\u00a02.27, 95% CI: 1.48\u20133.47,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =\u00a00.0002) and epinephrine use (RR\u00a0=\u00a02.05, 95% CI: 1.35\u20133.12,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =\u00a00.0008). Adverse effects such as gastrointestinal symptoms, respiratory events, and skin abnormalities were more frequent in the POIT group, leading to a higher treatment discontinuation rate (RR\u00a0=\u00a02.50, 95% CI: 1.20\u20135.21,\n                      <jats:italic toggle=\"yes\">P<\/jats:italic>\n                      =\u00a00.01).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion:<\/jats:title>\n                    <jats:p>POIT is effective in inducing desensitization in peanut-allergic individuals but carries significant risks, including an increased likelihood of anaphylaxis and adverse events. These findings reinforce previous meta-analyses and highlight the need for individualized risk-benefit assessments in clinical practice. Further research is required to optimize treatment protocols and improve patient safety.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1097\/ms9.0000000000004974","type":"journal-article","created":{"date-parts":[[2026,6,8]],"date-time":"2026-06-08T10:00:44Z","timestamp":1780912844000},"page":"4393-4401","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":0,"title":["Oral immunotherapy for peanut allergy: a systematic review and meta-analysis"],"prefix":"10.1097","volume":"88","author":[{"ORCID":"https:\/\/orcid.org\/0009-0002-7953-0022","authenticated-orcid":false,"given":"Muhammad","family":"Waaiz","sequence":"first","affiliation":[{"name":"Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4736-9263","authenticated-orcid":false,"given":"Waniya Badar","family":"Khan","sequence":"additional","affiliation":[{"name":"Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-4040-1697","authenticated-orcid":false,"given":"Rimsha","family":"Adnan","sequence":"additional","affiliation":[{"name":"Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0812-9477","authenticated-orcid":false,"given":"Shiza","family":"Abid","sequence":"additional","affiliation":[{"name":"Department of Medicine, Ayub Medical College, Abbottabad, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-9549-5674","authenticated-orcid":false,"given":"Muhammad Saad","family":"Khurshid","sequence":"additional","affiliation":[{"name":"Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-2391-9533","authenticated-orcid":false,"given":"Jamal Nasir","family":"Karim","sequence":"additional","affiliation":[{"name":"Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0004-3939-6716","authenticated-orcid":false,"given":"Saira Jahangir","family":"Khan","sequence":"additional","affiliation":[{"name":"Department of Medicine, Shaheed Mohtarma Benazir Bhutto Medical College Lyari, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-0513-1731","authenticated-orcid":false,"given":"Eman","family":"Javed","sequence":"additional","affiliation":[{"name":"Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0001-5819-0498","authenticated-orcid":false,"given":"Syeda Laiba","family":"Fahim","sequence":"additional","affiliation":[{"name":"Department of Medicine, Dow University of Health Sciences, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0196-3346","authenticated-orcid":false,"given":"Verkha","family":"Kumari","sequence":"additional","affiliation":[{"name":"Department of Medicine, Liaquat National Hospital and Medical College, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-2615-3389","authenticated-orcid":false,"given":"Muzainah","family":"Tabassum","sequence":"additional","affiliation":[{"name":"Department of Medicine, Jinnah Sindh Medical University, Karachi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1771-2149","authenticated-orcid":false,"given":"Qurat Ul Ain","family":"Muhammad","sequence":"additional","affiliation":[{"name":"Department of Medicine, Rawalpindi Medical University, Rawalpindi, Pakistan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9223-7800","authenticated-orcid":false,"given":"Pratik","family":"Bhattarai","sequence":"additional","affiliation":[{"name":"Department of Medicine, Manipal College of Medical Sciences, Pokhara, Nepal"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","published-online":{"date-parts":[[2026,6,9]]},"reference":[{"key":"R1-20261029","first-page":"100082","article-title":"Transparency in the reporting of Artificial Intelligence \u2013 the TITAN guideline","volume":"10","author":"Agha","year":"2025","journal-title":"Prem J Sci"},{"key":"R2-20261029","doi-asserted-by":"crossref","first-page":"2222\u201332","DOI":"10.1016\/S0140-6736(19)30420-9","article-title":"Oral immunotherapy for peanut allergy (PACE): a systematic review and meta-analysis of efficacy and safety","volume":"393","author":"Chu","year":"2019","journal-title":"Lancet"},{"key":"R3-20261029","doi-asserted-by":"crossref","first-page":"151\u201359","DOI":"10.18176\/jiaci.0143","article-title":"Oral Immunotherapy for Food Allergy","volume":"27","author":"Wood","year":"2017","journal-title":"J Investig Allergol Clin Immunol"},{"key":"R4-20261029","doi-asserted-by":"crossref","first-page":"889\u201399","DOI":"10.1056\/NEJMoa2312382","article-title":"Omalizumab for the treatment of multiple food allergies","volume":"390","author":"Wood","year":"2024","journal-title":"N Engl J Med"},{"key":"R5-20261029","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s11894-018-0624-y","article-title":"Food allergy","volume":"20","author":"Iweala","year":"2018","journal-title":"Curr Gastroenterol Rep"},{"key":"R6-20261029","doi-asserted-by":"crossref","first-page":"e20192102","DOI":"10.1542\/peds.2019-2102","article-title":"Peanut allergy: new advances and ongoing controversies","volume":"145","author":"Abrams","year":"2020","journal-title":"Pediatrics"},{"key":"R7-20261029","doi-asserted-by":"crossref","first-page":"785\u201395","DOI":"10.1080\/1744666X.2023.2209318","article-title":"Peanut allergy: risk factors, immune mechanisms, and best practices for oral immunotherapy success","volume":"19","author":"Tirumalasetty","year":"2023","journal-title":"Expert Rev Clin Immunol"},{"key":"R8-20261029","doi-asserted-by":"crossref","first-page":"104\u201309","DOI":"10.3949\/ccjm.88a.20130","article-title":"Oral immunotherapy: the answer to peanut allergy?","volume":"88","author":"Whitsel","year":"2021","journal-title":"Cleve Clin J Med"},{"key":"R9-20261029","first-page":"790\u201399","article-title":"Declaraci\u00f3n PRISMA 2020: una gu\u00eda actualizada para la publicaci\u00f3n de revisiones sistem\u00e1ticas","volume":"74","author":"Page","year":"2021","journal-title":"Rev Esp Cardiol Engl Ed"},{"key":"R10-20261029","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1186\/s13643-016-0384-4","article-title":"Rayyan\u2014a web and mobile app for systematic reviews","volume":"5","author":"Ouzzani","year":"2016","journal-title":"Syst Rev"},{"key":"R11-20261029","doi-asserted-by":"crossref","first-page":"l4898","DOI":"10.1136\/bmj.l4898","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"Bmj"},{"key":"R12-20261029","doi-asserted-by":"crossref","first-page":"1297\u2013304","DOI":"10.1016\/S0140-6736(13)62301-6","article-title":"Assessing the efficacy of oral immunotherapy for the desensitisation of peanut allergy in children (STOP II): a phase 2 randomised controlled trial","volume":"383","author":"Anagnostou","year":"2014","journal-title":"Lancet"},{"key":"R13-20261029","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/j.jaci.2014.11.034","article-title":"Administration of a probiotic with peanut oral immunotherapy: a randomized trial","volume":"135","author":"Tang","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"R14-20261029","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.jaip.2017.09.016","article-title":"Efficacy and Safety of AR101 in oral immunotherapy for peanut allergy: results of ARC001, a randomized, double-blind, placebo-controlled phase 2 clinical trial","volume":"6","author":"Bird","year":"2018","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R15-20261029","first-page":"1991\u20132001","article-title":"AR101 oral immunotherapy for peanut allergy","volume":"379","year":"2018","journal-title":"N Engl J Med"},{"key":"R16-20261029","doi-asserted-by":"crossref","first-page":"728\u201339","DOI":"10.1016\/S2352-4642(20)30234-0","article-title":"Efficacy and safety of oral immunotherapy with AR101 in European children with a peanut allergy (ARTEMIS): a multicentre, double-blind, randomised, placebo-controlled phase 3 trial","volume":"4","author":"Ob Hourihane","year":"2020","journal-title":"Lancet Child Adolesc Health"},{"key":"R18-20261029","doi-asserted-by":"crossref","first-page":"654\u201360","DOI":"10.1016\/j.jaci.2010.12.1111","article-title":"A randomized controlled study of peanut oral immunotherapy: clinical desensitization and modulation of the allergic response","volume":"127","author":"Varshney","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"R19-20261029","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.jaci.2014.11.005","article-title":"A randomized, double-blind, placebo-controlled pilot study of sublingual versus oral immunotherapy for the treatment of peanut allergy","volume":"135","author":"Narisety","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"R20-20261029","doi-asserted-by":"crossref","first-page":"274\u201381","DOI":"10.1111\/apa.13668","article-title":"Double-blind placebo-controlled challenge showed that peanut oral immunotherapy was effective for severe allergy without negative effects on airway inflammation","volume":"106","author":"Kukkonen","year":"2017","journal-title":"Acta Paediatr"},{"key":"R23-20261029","doi-asserted-by":"crossref","first-page":"181\u201388","DOI":"10.1159\/000486310","article-title":"Oral Immunotherapy in Japanese Children with Anaphylactic Peanut Allergy","volume":"175","author":"Nagakura","year":"2018","journal-title":"Int Arch Allergy Immunol"},{"key":"R25-20261029","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.jaip.2018.10.048","article-title":"Efficacy, safety, and quality of life in a multicenter, randomized, placebo-controlled trial of low-dose peanut oral immunotherapy in children with peanut allergy","volume":"7","author":"Blumchen","year":"2019","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R26-20261029","doi-asserted-by":"crossref","first-page":"862\u201374","DOI":"10.1111\/cea.13148","article-title":"Peanut gastrointestinal delivery oral immunotherapy in adolescents: results of the build-up phase of a randomized, double-blind, placebo-controlled trial (PITA study)","volume":"48","author":"Fauquert","year":"2018","journal-title":"Clin Exp Allergy"},{"key":"R27-20261029","doi-asserted-by":"crossref","first-page":"337\u201348","DOI":"10.1111\/all.13604","article-title":"Feasibility of desensitizing children highly allergic to peanut by high-dose oral immunotherapy","volume":"74","author":"Reier-Nilsen","year":"2019","journal-title":"Allergy"},{"key":"R28-20261029","doi-asserted-by":"crossref","first-page":"512\u201318","DOI":"10.1111\/pai.12898","article-title":"Low-dose oral immunotherapy for children with anaphylactic peanut allergy in Japan","volume":"29","author":"Nagakura","year":"2018","journal-title":"Pediatr Allergy Immunol"},{"key":"R29-20261029","doi-asserted-by":"crossref","first-page":"1437\u201349","DOI":"10.1016\/S0140-6736(19)31793-3","article-title":"Sustained outcomes in oral immunotherapy for peanut allergy (POISED study): a large, randomised, double-blind, placebo-controlled, phase 2 study","volume":"394","author":"Chinthrajah","year":"2019","journal-title":"Lancet"},{"key":"R30-20261029","doi-asserted-by":"crossref","first-page":"359\u201371","DOI":"10.1016\/S0140-6736(21)02390-4","article-title":"Efficacy and safety of oral immunotherapy in children aged 1\u20133 years with peanut allergy (the Immune Tolerance Network IMPACT trial): a randomised placebo-controlled study","volume":"399","author":"Jones","year":"2022","journal-title":"Lancet"},{"key":"R31-20261029","doi-asserted-by":"crossref","first-page":"AB82","DOI":"10.1016\/j.jaci.2018.12.254","article-title":"Successful desensitisation and sustained unresponsiveness using modified peanut: results from the BOPI study","volume":"143","author":"Patel","year":"2019","journal-title":"J Allergy Clin Immunol"},{"key":"R32-20261029","doi-asserted-by":"crossref","first-page":"1852\u201362","DOI":"10.1111\/all.15211","article-title":"Allergen immunotherapy and\/or biologicals for IgE-mediated food allergy: a systematic review and meta-analysis","volume":"77","author":"De Silva","year":"2022","journal-title":"Allergy"},{"key":"R33-20261029","doi-asserted-by":"crossref","first-page":"108820","DOI":"10.1016\/j.clim.2021.108820","article-title":"Memory and na\u00efve gamma delta regulatory T-cell gene expression in the first 24-weeks of peanut oral immunotherapy","volume":"230","author":"Anvari","year":"2021","journal-title":"Clin Immunol"},{"key":"R34-20261029","doi-asserted-by":"crossref","first-page":"803\u201311","DOI":"10.1111\/all.15537","article-title":"Efficacy and safety of food allergy oral immunotherapy in adults","volume":"78","author":"Epstein-Rigbi","year":"2023","journal-title":"Allergy"},{"key":"R35-20261029","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jaip.2021.11.005","article-title":"Elevated Cow\u2019s milk\u2013specific IgE levels prior to oral immunotherapy decrease the likelihood of reaching the maintenance dose","volume":"10","author":"Cohen","year":"2022","journal-title":"J Allergy Clin Immunol Pract"},{"key":"R36-20261029","doi-asserted-by":"crossref","first-page":"125\u201337","DOI":"10.1007\/s12016-024-08990-8","article-title":"From skin to solution: exploring epicutaneous immunotherapy for peanut allergy\u2014a systematic review and meta-analysis","volume":"66","author":"Banatwala","year":"2024","journal-title":"Clin Rev Allergy Immunol"},{"key":"R37-20261029","doi-asserted-by":"crossref","first-page":"170\u201382","DOI":"10.1159\/000504366","article-title":"The efficacy and safety of epicutaneous immunotherapy for allergic diseases: a systematic review and meta-analysis","volume":"181","author":"Xiong","year":"2020","journal-title":"Int Arch Allergy Immunol"},{"key":"R38-20261029","doi-asserted-by":"crossref","first-page":"317\u201328","DOI":"10.1038\/s41577-022-00786-1","article-title":"Allergen immunotherapy: past, present and future","volume":"23","author":"Durham","year":"2023","journal-title":"Nat Rev Immunol"},{"key":"R39-20261029","doi-asserted-by":"crossref","first-page":"ltac004","DOI":"10.1093\/immadv\/ltac004","article-title":"Peanut oral immunotherapy: current trends in clinical trials","volume":"2","author":"Reinwald","year":"2022","journal-title":"Immunother Adv"},{"key":"R40-20261029","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/s41598-019-56961-3","article-title":"Adverse events associated with peanut oral immunotherapy in children \u2013 a systematic review and meta-analysis","volume":"10","author":"Grzeskowiak","year":"2020","journal-title":"Sci Rep"},{"key":"R41-20261029","doi-asserted-by":"crossref","first-page":"636612","DOI":"10.3389\/fimmu.2021.636612","article-title":"Oral immunotherapy for food-allergic children: a pro-con debate","volume":"12","author":"Mori","year":"2021","journal-title":"Front Immunol"}],"container-title":["Annals of Medicine &amp; Surgery"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/10.1097\/MS9.0000000000004974","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T04:02:17Z","timestamp":1793246537000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.1097\/MS9.0000000000004974"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,9]]},"references-count":37,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026]]}},"URL":"https:\/\/doi.org\/10.1097\/ms9.0000000000004974","relation":{},"ISSN":["2049-0801","2049-0801"],"issn-type":[{"value":"2049-0801","type":"electronic"},{"value":"2049-0801","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6,9]]},"assertion":[{"value":"2025-11-19","name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2026-03-19","name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}}]}}